Posts By :

Thomas Prevot

New Research Article shows Beneficial Effects of a New Drug in Transgenic Mouse Model with Cognitive Dysfunctions and Anxiety Phenotype

New Research Article shows Beneficial Effects of a New Drug in Transgenic Mouse Model with Cognitive Dysfunctions and Anxiety Phenotype 613 472 Thomas Prevot

The paper was published by Fee et al. in the International Journal of Neuropsychopharmacology. Patients suffering from mood and anxiety disorders often exhibit a deficit in brain inhibition. This deficit in brain inhibition is due do dysfunctional somatostatin (SST) cells, causing mood and cognitive symptoms in patients. Using transgenic mice in which the SST cell…

read more

A new molecule shows efficacy at reversing brain atrophy observed during aging

A new molecule shows efficacy at reversing brain atrophy observed during aging 639 450 Thomas Prevot

Drs. Prevot, Sibille and Colleagues just published their finding in the Journal Cerebral Cortex, about a new molecule reversing brain atrophy and memory dysfunction observed during aging. During aging, our brain tends to slowly shrink in size due to neuronal shrinkage and reduced function. This phenomenon participates in the emergence of cognitive and memory deficits,…

read more

Alpha Cog graduates from the Creative Destructive Lab – Edition 2019-2020

Alpha Cog graduates from the Creative Destructive Lab – Edition 2019-2020 256 256 Thomas Prevot

Our team is proud of being part of the graduating ventures participating in the 2019-2020 Edition of the Creative Destruction Lab (CDL). CDL is a nonprofit organization that delivers an objectives-based program for massively scalable, seed-stage, science- and technology-based companies. Alpha Cog participated in the Health Stream, and received valuable inputs from mentors from September…

read more